Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17990908 | 0.98 | KDM4E (0.36) | L3MBTL1KDM4EATMLIMK1HDAC4 | |
| SCHEMBL17990946 | 0.93 | KDM4E (0.34) | L3MBTL1KDM4EATMLIMK1KMT2A | |
| SCHEMBL17990840 | 0.92 | KDM4E (0.33) | L3MBTL1KDM4EATMLIMK1CYP1A1 | |
| SCHEMBL19382801 | 0.91 | ATM (0.36) | L3MBTL1KDM4EATMLIMK1KMT2A | |
| SCHEMBL24676596 | 0.88 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMLIMK1HDAC4 | |
| SCHEMBL15126634 | 0.88 | LIMK1 (0.40) | L3MBTL1KDM4EATMLIMK1HDAC4 | |
| SCHEMBL24676248 | 0.86 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMLIMK1HDAC4 | |
| SCHEMBL24518987 | 0.86 | LIMK1 (0.36) | L3MBTL1KDM4EATMLIMK1CYP1A1 | |
| SCHEMBL10014563 | 0.86 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMLIMK1HDAC4 | |
| SCHEMBL17690959 | 0.86 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMHDAC4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210242410-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-08-05 | — | — | US | disclosed |
| US-11008280-B2 | Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element | DUK SAN NEOLUX CO., LTD. (KR) | 2021-05-18 | — | — | US | disclosed |
| US-20190296248-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
| US-20190135730-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | DUK SAN NEOLUX CO., LTD. (KR) | 2019-05-09 | — | — | US | disclosed |
| EP-3431476-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFROM | Duk San Neolux Co., Ltd. (KR) | 2019-01-23 | — | — | EP | disclosed |
| US-20180123051-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180123051-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| WO-2018026197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME | 덕산네오룩스 주식회사 | 2018-02-08 | — | — | WO | disclosed |
| WO-2017204556-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2017-11-30 | — | — | WO | disclosed |
| WO-2017188655-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | 덕산네오룩스 주식회사 | 2017-11-02 | — | — | WO | disclosed |
| WO-2017160089-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFROM | 덕산네오룩스 주식회사 | 2017-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123051-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | L3MBTL1 1026/4885KDM4E 1506/4885ATM 4024/4885 |
| US-20210242410-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | L3MBTL1 1026/4885KDM4E 1506/4885ATM 4024/4885 |
| US-11008280-B2 | Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element | ORAI2, PIEZO1, ORC3 | L3MBTL1 3094/4885KDM4E 1140/4885ATM 2563/4885 |
| US-20190135730-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | ORAI2, PIEZO1, ORC3 | L3MBTL1 3094/4885KDM4E 1140/4885ATM 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.